Yiu ZZN, Mason KJ, Hampton PJ, Reynolds NJ, et al. Drug Survival of Adalimumab, Ustekinumab, and Secukinumab in Patients with Psoriasis: a Prospective Cohort Study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). Br J Dermatol 2020 Mar 2. doi: 10.1111/bjd.18981.
PMID: 32124442